Group One Trading’s enVVeno Medical NVNO Stock Holding History

Group One Trading’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-114	Closed	-$3.62K	–	8843
2025 Q3	$3.62K	Sell	114 -6,249	-98%	-$638K	﹤0.01%	7691
2025 Q2	$889K	Buy	6,363 +6,334	+21,841%	+$749K	﹤0.01%	2886
2025 Q1	$2.63K	Buy	+29	New	+$3.23K	﹤0.01%	6906
2024 Q4	–	Sell	-54	Closed	-$6.38K	–	7745
2024 Q3	$6.38K	Sell	54 -4,375	-99%	-$804K	﹤0.01%	5788
2024 Q2	$814K	Sell	4,429 -7,457	-63%	-$1.3M	﹤0.01%	2164
2024 Q1	$2.26M	Buy	11,886 +840	+8%	+$151K	0.01%	1398
2023 Q4	$1.99M	Buy	11,046 +7,009	+174%	+$1.12M	0.01%	1885
2023 Q3	$762K	Buy	+4,037	New	+$673K	﹤0.01%	2531
2023 Q1	–	Sell	-3,300	Closed	-$589K	–	7705
2022 Q4	$589K	Sell	3,300 -1,594	-33%	-$324K	﹤0.01%	2894
2022 Q3	$1.08M	Buy	4,894 +2,383	+95%	+$507K	﹤0.01%	2511
2022 Q2	$332K	Buy	2,511 +514	+26%	+$79.7K	﹤0.01%	3819
2022 Q1	$445K	Buy	1,997 +960	+93%	+$186K	﹤0.01%	3938
2021 Q4	$239K	Buy	+1,037	New	+$292K	﹤0.01%	4914

Other funds holding NVNO

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Group One Trading's NVNO Position: Q2 2026 in Review

Group One Trading held its enVVeno Medical (NVNO) position steady in Q2 2026 at 2 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7443.

Group One Trading first reported a position in NVNO in Q3 2023 and has held it in 7 quarters since. The position peaked at $34.3K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

Group One Trading held 2 shares of enVVeno Medical worth $21 as of Q2 2026.
Group One Trading left its enVVeno Medical share count unchanged in Q2 2026.
enVVeno Medical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7443 holding.
Group One Trading first reported a position in enVVeno Medical in Q3 2023 and has held it in 7 quarters since.
Group One Trading's enVVeno Medical position peaked at $34.3K in Q3 2023.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.